VB Spine Secures French Production Base from Stryker
On January 6, 2026, privately-held VB Spine LLC completed its acquisition of a spine implant manufacturing facility in Cestas, France, from medical technology giant Stryker (NYSE: SYK). The deal includes the transfer of the site's entire workforce, infrastructure, and operational processes, ensuring no interruption to manufacturing. This purchase provides VB Spine with a state-of-the-art European production base, which the company states will anchor its worldwide manufacturing capabilities.
Acquisition Follows April 2025 U.S. Business Purchase
The Cestas facility acquisition is a direct extension of VB Spine's formation on April 1, 2025, when it was established by acquiring Stryker’s U.S. spine implant business. Both transactions are led by the Viscogliosi Brothers, a family office with a long history of building companies in the neuro-musculoskeletal sector. By integrating the French facility, VB Spine advances its strategy of creating a fully independent, global entity with comprehensive design, manufacturing, and distribution capabilities.
Move Solidifies Position as Largest Private Spine Firm
This transaction cements VB Spine's standing as the world's largest privately owned company focused exclusively on the spine market. The company plans to leverage the Cestas facility to expand its medical education and surgeon training programs in Europe. For Stryker, the divestiture represents a continued strategic narrowing of its focus, shedding non-core assets to concentrate on its primary growth areas. The deal positions VB Spine to compete more aggressively by controlling a larger portion of its supply chain and strengthening its global distribution network.